Study evaluating the pharmacokinetics, safety and tolerability of Voriconazole in children aged 2-12 years who require treatment of systemic fungal infection

Mise à jour : Il y a 5 ans
Référence : EUCTR2014-004183-38

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To investigate the pharmacokinetics of voriconazole following multiple dosing with intravenous voriconazole in children aged 2 to less than (<)12 years.


Critère d'inclusion

  • Systemic Fungal Infection

Liens